
AI-native pharma marketing startup Solstice raises $21M to cut drug campaign timelines from 3 months to 10 days - Tech Funding News
Solstice is an AI-native pharma marketing startup that aims to streamline the marketing and regulatory review processes for pharmaceutical companies. By leveraging AI technology, it significantly reduces the time required for campaign approvals, allowing companies to launch marketing campaigns in as little as 10 days. The startup has already partnered with several top pharmaceutical brands to enhance their marketing efficiency.
AI-native pharma marketing startup Solstice raises $21M to cut drug campaign timelines from 3 months to 10 days Tech Funding News

| Jun 11, 2026 | Current | $80.0M | — | United States |
| Jun 11, 2026 | Endurance Energy | $54.0M | Series A | United States |
| Jun 11, 2026 | Neion Bio | $23.0M | Series A | United States |
| Jun 11, 2026 | Coram | $35.0M | Series B | United States |